FDA grants priority review to zanidatamab for HER2-positive biliary tract cancer based on Phase ...
Bestof

FDA grants priority review to zanidatamab for HER2-positive biliary tract cancer based on Phase ...

1920 × 1280 px May 2, 2025 Zeus

FDA grants priority review to zanidatamab for HER2-positive biliary tract cancer based on Phase ... is a high-quality image in the Bestof collection, available at 1920 × 1280 pixels resolution — ideal for both digital and print use.

Understand Research Grant F and A rates. Learn how indirect costs, overhead, and sponsor policies impact your academic funding and budget management today.

Image Details

TitleFDA grants priority review to zanidatamab for HER2-positive biliary tract cancer based on Phase ...
Dimensions1920 × 1280 px
CategoryBestof
PublishedMay 2, 2025
AuthorZeus
Downloads1,212
Views1,214

Frequently Asked Questions

This image has a resolution of 1920 × 1280 pixels. It is suitable for high-quality printing, digital presentations, and web use without losing clarity.
This image is part of the Bestof collection. You can browse more images in this category to find similar content.
Click the Download button above the image to save it directly to your device. The image is provided in its original resolution of 1920 × 1280 px.
Yes! Scroll down to the More Images section below to explore related Bestof images. You can also visit the full article for more context and a complete image gallery.

Read full article: Research Grant F And A Rate

More Images